ABSTRACT
Official Covid-19 death tallies have under-estimated the total mortality impact of the Covid-19 pandemic. Excess mortality is a useful measure for assessing the total effects of the pandemic on mortality levels. While most studies of excess mortality in the United States have taken place at the state or national levels, some studies have produced county-level estimates. However, no estimates are currently available for the period from 2020 to 2021. In the present study, we estimate two hierarchical linear models to predict county-level death rates using mortality data by county of residence from January 2015 to December 2019. After fitting the models, we generate estimates of expected deaths for each month in the period from March 2020 to December 2021 and compare these estimates with the observed number of deaths to obtain counts of excess deaths. An estimated 936,911 excess deaths occurred during 2020 and 2021, of which 171,168 were not assigned to Covid-19 on death certificates. In the Far West, Great Lakes, Mideast, and New England, there was a substantial urban mortality disadvantage in 2020, which was reversed in 2021 to yield a rural mortality disadvantage. In the Southeast, Southwest, Rocky Mountain, and Plains regions, there was a rural mortality disadvantage in 2020, which was exacerbated in 2021. The proportion of excess deaths assigned to Covid-19 was lower in 2020 (76.3%) than in 2021 (87.0%), suggesting fewer Covid-19 deaths went unassigned later in the pandemic. However, in rural areas and in the Southeast and Southwest many excess deaths were still not assigned to Covid-19 during 2021.
SIGNIFICANCE Deaths during the Covid-19 pandemic have been primarily monitored through death certificates containing reference to Covid-19. This approach has missed more than 180,000 deaths related to the pandemic between 2020 and 2021. While the ascertainment of Covid-19 deaths improved in some regions during 2021, the full effects of the pandemic still remained obscured in other regions. County-level estimates of excess mortality are useful for studying geographic inequities in the mortality burden associated with the pandemic and identifying specific regions where the full mortality burden was significantly underreported (i.e. Southeast and Southwest). They can also be used to inform resource allocation decisions at the federal and state levels (i.e. FEMA funeral assistance) and encourage uptake of preventive measures in communities with low vaccine uptake.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors gratefully acknowledge financial support from the Robert Wood Johnson Foundation (77521), the National Institute on Aging (R01-AG060115-04 and R01-AG060115-04S1) and the W.K. Kellogg Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used in the present manuscript are publicly available from the Centers for Disease Control and Prevention and U.S. Census Bureau. Additional details about the data and programming code for replicating the analyses of the present study can be accessed at the linked GitHub repository. https://github.com/Mortality-Surv-and-Reporting-Proj/monthly_county_level_excess_mortality
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data used in the present manuscript are publicly available from the Centers for Disease Control and Prevention and U.S. Census Bureau. Additional details about the data and programming code for replicating the analyses of the present study can be accessed at the linked GitHub repository. https://github.com/Mortality-Surv-and-Reporting-Proj/monthly_county_level_excess_mortality
